Richard Ries, MD, FAPA, FASM

Faculty Appointment(s)

Professor, Department of Psychiatry and Behavioral Sciences

Leadership Role(s)

Director, Division of Addictions

Co-Director, Psychiatry and Addictions Case Conference (PACC) series

rries@uw.edu

206-341-4216

UW Medicine profile »

Personal Statement

I am a Professor of Psychiatry and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington  School of Medicine in Seattle, Washington. I am also the clinical director of  addictions treatment services at Harborview Medical Center, and work in the psychiatric rehabilitation and recovery services.

I am board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine. A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, I am on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health.

Education

Northwestern Univ. Medical School Medical education, 1975
UW - Dept. of Psychiatry & Behavioral Sciences Residency, Psychiatry

Department Affiliations

Centers/Programs
Training Programs

Recent Publications

Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults.
(2021 Dec 11)
J Subst Abuse Treat
Hirchak KA, Lyons AJ, Herron JL, Kordas G, Shaw JL, Jansen K, Avey JP, McPherson SM, Donovan D, Roll J, Buchwald D, Ries R, McDonell MG, HONOR Study Team.
Development and Initial Pilot Testing of a fully integrated treatment for comorbid social anxiety disorder and alcohol use disorder in a community-based SUD clinic setting.
(2022 Jan)
Behav Res Ther 148(): 103999
Wolitzky-Taylor K, Sewart A, Karno M, Ries R, Stimson J
What do clinicians want? Understanding frontline addiction treatment clinicians' preferences and priorities to improve the design of measurement-based care technology.
(2021 Jun 15)
Addict Sci Clin Pract 16(1): 38
Tauscher JS, Cohn EB, Johnson TR, Diteman KD, Ries RK, Atkins DC, Hallgren KA
Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
(2021 Apr)
Lancet Psychiatry 8(4): 287-300
Collins SE, Duncan MH, Saxon AJ, Taylor EM, Mayberry N, Merrill JO, Hoffmann GE, Clifasefi SL, Ries RK
Effect of Incentives for Alcohol Abstinence in Partnership With 3 American Indian and Alaska Native Communities: A Randomized Clinical Trial.
(2021 Jun 1)
JAMA Psychiatry 78(6): 599-606
McDonell MG, Hirchak KA, Herron J, Lyons AJ, Alcover KC, Shaw J, Kordas G, Dirks LG, Jansen K, Avey J, Lillie K, Donovan D, McPherson SM, Dillard D, Ries R, Roll J, Buchwald D, HONOR Study Team.
Show complete publication list »
Edit Profile